Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 70Carcinoma, Hepatocellular 4Carcinoma, Renal Cell 3Prostate Adenocarcinoma 2Ovarian Neoplasms 2Neoplasms 2Carcinoma, Adenoid Cystic 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage II Prostate Adenocarcinoma 1Prostatic Diseases 1Prostate-specific Membrane Antigen 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Lobular 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 4olaparib 1gallium 68 PSMA-11 1durvalumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Lutetium-177 1Immunoglobulin G 1Disulfides 1Congresses as Topic 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Biochemically Recurrent Prostate Carcinoma × gallium 68 PSMA-11 × Clear all
NCT04216134 2023-06-15

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

City of Hope Medical Center

Phase 1 Completed
19 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡